Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Lustig · SciRah

Researcher profile · Semantic Scholar

Y. Lustig

Share profile

Y. Lustig — researcher profile on SciRah

h-index: 39
Works: 156
Citations: 7,958

Most-cited papers

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
E. G. Levin, Y. Lustig, C. Cohen, Ronen Fluss +10 more
2021New England Journal of Medicine1,583 citations Open access
Semantic Scholar
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
Ital Nemet, L. Kliker, Y. Lustig, N. Zuckerman +7 more
2021medRxiv404 citations Open access
Semantic Scholar
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
G. Regev-Yochay, T. Gonen, M. Gilboa, M. Mandelboim +16 more
2022New England Journal of Medicine354 citations Open access
Semantic Scholar
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
M. Lipsitch, F. Krammer, G. Regev-Yochay, Y. Lustig +1 more
2021Nature reviews. Immunology289 citations Open access
Semantic Scholar
Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection
Salma Sheikh-Mohamed, G. Chao, B. Isho, Michelle Zuo +36 more
2022Mucosal Immunology263 citations Open access
Semantic Scholar
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
Y. Lustig, N. Zuckerman, Ital Nemet, N. Atari +7 more
2021Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin132 citations Open access
Semantic Scholar
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response
Y. Peled, E. Ram, J. Lavee, L. Sternik +8 more
2021The Journal of Heart and Lung Transplantation120 citations Open access
Semantic Scholar
Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel
G. Regev-Yochay, S. Amit, Moriah Bergwerk, M. Lipsitch +13 more
2021The Lancet Regional Health - Europe116 citations Open access
Semantic Scholar
Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection
M. Gilboa, G. Regev-Yochay, M. Mandelboim, V. Indenbaum +9 more
2022JAMA Network Open115 citations Open access
Semantic Scholar
Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy
O. Nir, A. Schwartz, S. Toussia-Cohen, L. Leibovitch +8 more
2021American Journal of Obstetrics & Gynecology MFM103 citations Open access
Semantic Scholar
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience
Y. Peled, E. Ram, J. Lavee, A. Segev +12 more
2021The Journal of Heart and Lung Transplantation95 citations Open access
Semantic Scholar
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose
Y. Lustig, T. Gonen, Lilac Meltzer, M. Gilboa +12 more
2022Nature Immunology86 citations Open access
Semantic Scholar
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study
G. Regev-Yochay, Y. Lustig, Gili Joseph, M. Gilboa +19 more
2023The Lancet Microbe82 citations Open access
Semantic Scholar
BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study
G. Rahav, Y. Lustig, Jacob Lavee, O. Benjamini +15 more
2021EClinicalMedicine72 citations Open access
Semantic Scholar
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
O. Benjamini, L. Rokach, G. Itchaki, A. Braester +14 more
2021Haematologica63 citations Open access
Semantic Scholar
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
Inbal Farkash, T. Feferman, Noy Cohen-Saban, Yahel Avraham +10 more
2021Cell Reports60 citations Open access
Semantic Scholar
The Role of NS1 Protein in the Diagnosis of Flavivirus Infections
Ron Fisher, Y. Lustig, E. Sklan, Eli Schwartz
2023Viruses50 citations Open access
Semantic Scholar
A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients
Yana Davidov, V. Indenbaum, K. Tsaraf, O. Cohen-ezra +10 more
2022Journal of Hepatology49 citations Open access
Semantic Scholar
Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
E. Shmueli, Amit Itay, O. Margalit, R. Berger +8 more
2021European Journal of Cancer46 citations Open access
Semantic Scholar
Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose
M. Canetti, N. Barda, M. Gilboa, V. Indenbaum +10 more
2022New England Journal of Medicine45 citations Open access
Semantic Scholar
Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies
Tammy Hod, A. Ben-David, L. Olmer, I. Levy +4 more
2021Transplantation41 citations Open access
Semantic Scholar
Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
S. Reicher, Ronit Ratzon, Shay Ben-Sahar, Sharon Hermoni-Alon +8 more
2021European Journal of Epidemiology39 citations Open access
Semantic Scholar
Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients
Yana Davidov, K. Tsaraf, O. Cohen-ezra, M. Likhter +7 more
2021Liver transplantation37 citations Open access
Semantic Scholar
Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines
T. Gonen, N. Barda, K. Asraf, Gili Joseph +5 more
2023JAMA Network Open36 citations Open access
Semantic Scholar
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel
M. Gilboa, T. Gonen, N. Barda, Shelly Cohn +16 more
2023JAMA Network Open33 citations Open access
Semantic Scholar
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up
M. Canetti, N. Barda, M. Gilboa, V. Indenbaum +12 more
2022Nature Communications27 citations Open access
Semantic Scholar
Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine
I. Levy, E. G. Levin, L. Olmer, G. Regev-Yochay +9 more
2022Vaccines26 citations Open access
Semantic Scholar
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity.
A. Muik, B. G. Lui, Jasmin Quandt, Huitian Diao +17 more
2023Cell Reports23 citations Open access
Semantic Scholar
Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine
A. Schwartz, O. Nir, S. Toussia-Cohen, Leah Leibovich +9 more
2021American Journal of Obstetrics and Gynecology22 citations Open access
Semantic Scholar
Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort Study
Gili Joseph, I. Margalit, Y. Weiss-Ottolenghi, C. Rubin +10 more
2024Viruses20 citations
Semantic Scholar
BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients
Tammy Hod, A. Ben-David, L. Olmer, N. Scott +7 more
2022Transplant International19 citations Open access
Semantic Scholar
Transfusion-transmitted infections: risks and mitigation strategies for Oropouche virus and other emerging arboviruses in Latin America and the Caribbean
A. Moreira-Soto, Ignacio Postigo-Hidalgo, Ximena Tabares, Yannik E. Roell +6 more
2025The Lancet Regional Health - Americas16 citations Open access
Semantic Scholar
Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023: a genomic epidemiology study.
N. Zuckerman, E. Bucris, Hagar Morad-Eliyahu, L. Weiss +15 more
2024The Lancet Microbe16 citations Open access
Semantic Scholar
Early rise of West Nile fever in Israel, June 2024
Zohar Mor, Husein Omari, V. Indenbaum, O. Kirstein +9 more
2024Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin16 citations Open access
Semantic Scholar
Cellular and humoral response to the fourth BNT162b2 mRNA COVID‐19 vaccine dose in patients with CLL
O. Benjamini, Rotem Gershon, Erez Bar-Haim, Y. Lustig +10 more
2022European Journal of Haematology16 citations Open access
Semantic Scholar
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – implications for the omicron variant
Y. Peled, A. Afek, Y. Kreiss, G. Rahav +12 more
2022The Journal of Heart and Lung Transplantation15 citations Open access
Semantic Scholar
Under-diagnosis of SARS-CoV-2 infections among children aged 0–15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021
V. Indenbaum, Y. Lustig, E. Mendelson, Y. Hershkovitz +3 more
2021Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin15 citations Open access
Semantic Scholar
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up
N. Barda, Y. Lustig, V. Indenbaum, Daniel Zibly +17 more
2023Clinical Microbiology and Infection14 citations Open access
Semantic Scholar
The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection.
N. Barda, M. Canetti, M. Gilboa, K. Asraf +10 more
2022Clinical Infectious Diseases13 citations Open access
Semantic Scholar
Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study
Shirley Shapiro Ben David, B. Mizrahi, D. Rahamim-Cohen, L. Supino-Rosin +11 more
2022Vaccine12 citations Open access
Semantic Scholar
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes
A. Muik, B. G. Lui, Huitian Diao, Yunguan Fu +14 more
2022bioRxiv12 citations Open access
Semantic Scholar
Superior immunogenicity and effectiveness of the 3rd BNT162b2 vaccine dose
Y. Lustig, T. Gonen, Lilac Meltzer, M. Gilboa +12 more
2021medRxiv12 citations Open access
Semantic Scholar
The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021
N. Zuckerman, Ital Nemet, L. Kliker, N. Atari +16 more
2021Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin11 citations Open access
Semantic Scholar
West Nile Virus Outbreak in Israel 2024 Compared with Previous Seasons: A Retrospective Study
Guy Katzenellenbogen, M. Canetti, I. Margalit, Yonatan Shusterman +20 more
2025Infectious Disease and Therapy10 citations Open access
Semantic Scholar
Neutralizing Antibody Response to the AreXvy Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients: Assessment Against Reference and Seasonal Strains
Liran Levy, D. Yahav, Mark Benzimra, Y. Bezalel +12 more
2025Vaccines9 citations Open access
Semantic Scholar
Humoral Response to the Fourth BNT162b2 Vaccination and Link Between the Fourth Dose, Omicron Infection, and Disease Severity in Renal Transplant Recipients
Tammy Hod, A. Ben-David, E. Mor, L. Olmer +11 more
2022Transplantation9 citations Open access
Semantic Scholar
Identification of Hepatitis E Virus Genotypes 3 and 7 in Israel: A Public Health Concern?
R. Shirazi, P. Pozzi, Y. Gozlan, M. Wax +5 more
2021Viruses9 citations Open access
Semantic Scholar
Circulating lncRNAs as biomarkers for severe dengue using a machine learning approach.
Rodolfo Katz, N. M. Nguyen, Túlio de Lima Campos, V. Indenbaum +8 more
2025Journal of Infection8 citations Open access
Semantic Scholar
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines.
Y. Lustig, N. Barda, Y. Weiss-Ottolenghi, V. Indenbaum +9 more
2024Vaccine8 citations
Semantic Scholar
Measles Sequencing: Lessons Learned from a Large-Scale Outbreak
V. Indenbaum, E. Bucris, Keren Friedman, Tatyana Kushnir +10 more
2025Viruses7 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Regev-Yochay×27
Invite
G. Regev-Yochay — researcher profile on SciRah
V. Indenbaum×26
Invite
V. Indenbaum — researcher profile on SciRah
R. Doolman×19
Invite
R. Doolman — researcher profile on SciRah
Y. Kreiss×18
Invite
Y. Kreiss — researcher profile on SciRah

×17

Invite

K. Asraf — researcher profile on SciRah

E. Mendelson×16

Invite

E. Mendelson — researcher profile on SciRah

M. Mandelboim×13

Invite

M. Mandelboim — researcher profile on SciRah

Invite

G. Rahav — researcher profile on SciRah

Invite

S. Amit — researcher profile on SciRah

Invite

C. Cohen — researcher profile on SciRah

Invite

M. Gilboa — researcher profile on SciRah

Invite

I. Levy — researcher profile on SciRah